SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Trading Statement

27 Jul 2016 07:00

RNS Number : 3058F
Ebiquity PLC
27 July 2016
 

Ebiquity Plc

("the Company")

 

 

Trading Update

 

Ebiquity plc, the leading independent marketing analytics specialists, today announces a trading statement for the half year ended 30 June 2016.

 

Ebiquity continues to grow revenue and profit ahead of the equivalent period last year with overall performance broadly in line with market expectations.

 

The Media Value Measurement practice (MVM) continued to grow in the first half of the year, although we experienced a slow-down in the rate of growth as some contract renewals and new business awards were delayed - particularly in the US - as advertisers awaited the publication of the US Association of National Advertisers' (ANA) Media Transparency reports. We anticipate faster year on year revenue growth over the remainder of the year as advertisers action the ANA's recommendations, prepared in partnership with Ebiquity and FirmDecisions, which were released on 18 July.

 

The Marketing Performance Optimization practice (MPO) has generated significant growth across all markets and achieved record growth overall. We expect strong performance from this practice over the remainder of the year.

 

The Market Intelligence practice (MI), as previously reported, operates in a highly competitive environment with revenues for this business anticipated to decline. Revenue from our platform business (Portfolio) was broadly flat year on year outside the US where revenue reflected pressure on client budgets. Our project based business further contracted as expected although at a faster rate than planned. We are continuing to progress our product development and previews of our upcoming product launches have been well received by clients. These product enhancements should be available for the 2017 renewal season.

 

With approximately two-thirds of Group revenue denominated in non-Sterling currencies, we have received some revenue benefit from Sterling's weakness in the first half of the year. Should this continue, there will be further revenue benefit in the second half of the year, accompanied by a proportionate increase in costs and an overall neutral impact on operating margins.

 

The Company is confident of achieving Board expectations for the full year to 31 December 2016 with improved growth in MVM and a strong performance in MPO offsetting the weaker than initially anticipated performance from MI.

 

On 28 September 2016 the Company will release its interim report for the six month period ended 30 June 2016.

27 July 2016

 

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Andrew Beach (CFOO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

Toby Adcock (Corporate Broker)

020 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEASXKADSKEFF
Date   Source Headline
8th Sep 20087:00 amRNSAGM Statement
29th Aug 200810:23 amRNSTotal Voting Rights
7th Aug 20081:33 pmRNSHolding(s) in Company
7th Aug 20087:00 amRNSChange of Name to Ebiquity
28th Jul 20082:05 pmRNSHolding(s) in Company
23rd Jul 20087:00 amRNSFinal Results
11th Jun 20084:00 pmRNSHolding(s) in Company
3rd Jun 20087:00 amRNSTrading Statement
7th May 20084:10 pmRNSHolding(s) in Company
25th Apr 20087:00 amRNSStrategy update
24th Apr 20087:01 amRNSBoard appointment
3rd Apr 20088:41 amRNSDirector/PDMR Shareholding
12th Mar 200810:32 amRNSHolding(s) in Company
29th Feb 200812:15 pmRNSHolding(s) in Company
22nd Feb 20081:11 pmRNSDirectorate Change
6th Feb 20083:47 pmRNSHolding(s) in Company
4th Feb 20082:07 pmRNSHolding(s) in Company
4th Feb 20082:05 pmRNSHolding(s) in Company
24th Jan 20087:01 amRNSDirector/PDMR Shareholding
23rd Jan 20087:02 amRNSInterim Results
10th Jan 200810:11 amRNSNotice of Results
7th Dec 20073:39 pmRNSHolding(s) in Company
7th Dec 20079:17 amRNSHolding(s) in Company
8th Nov 20071:14 pmRNSHolding(s) in Company
31st Oct 20072:59 pmRNSTotal Voting Rights
29th Oct 20073:07 pmRNSAdditional Listing
29th Oct 20078:56 amRNSAdditional Listing
11th Oct 200712:35 pmRNSDirector/PDMR Shareholding
2nd Oct 20074:27 pmRNSDirector/PDMR Shareholding
28th Sep 20073:51 pmRNSTotal Voting Rights
27th Sep 20077:01 amRNSBoard Changes
21st Sep 200711:31 amRNSAdditional Listing
14th Sep 20072:42 pmRNSHolding in US Operation
6th Sep 200710:36 amRNSAGM Statement
15th Aug 20074:39 pmRNSAIM Rule 26
15th Aug 20078:00 amRNSChange of Adviser
24th Jul 20077:00 amRNSFinal Results
16th Jul 20072:41 pmRNSNotice of Results
10th Jul 20074:02 pmRNSNotice of Results
4th May 20077:01 amRNSDirector Shareholding
3rd May 200711:44 amRNSMarketing Spend Q1 07
3rd May 20079:58 amRNSHolding(s) in Company
2nd May 200711:55 amRNSGrant of Share Options
30th Apr 20077:03 amRNSSecond Interim Results
18th Apr 20077:01 amRNSBoard Appointment
10th Apr 20073:44 pmRNSNotice of Results
21st Mar 20073:01 pmRNSHolding(s) in Company
21st Mar 20072:57 pmRNSHolding(s) in Company
21st Mar 20072:44 pmRNSHolding(s) in Company
8th Mar 20077:01 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.